Th e objective of our study was to investigate the eff ect of Aliskiren, a renin inhibitor, on the deoxycorticosterone (DOCA) induced myocardial fi brosis in a rat model and its underlying mechanism. A total of  Sprague-Dawley (SD) rats underwent right nephrectomy and were randomly assigned into  groups: control group (CON group: silicone tube was embedded subcutaneously); DOCA treated group (DOC group:  mg of DOCA was subcutaneously administered); DOCA and Aliskiren (ALI) treated group (ALI group:  mg of DOCA and  mg/ kg/d ALI were subcutaneously and intragastrically given, respectively). Treatment was done for  weeks. Sirius red staining was employed to detect the expression of myocardial collagen, and the myocardial collagen volume fraction (CVF) and perivascular collagen volume area (PVCA) were calculated. Radioimmunoassay was carried out to measure the renin activity (RA) and content of angiotensin II (Ang II) in the plasma and ventricle. Western blot assay was done to detect the expressions of extracellular signal-regulated kinase / (ERK/), phosphorylated ERK/ (PERK/) and matrix metalloproteinase  (MMP-). In the DOC group and ALI group, the CVF and PVCA were signifi cantly increased; the RA and Ang II levels in the plasma and ventricle were remarkably lowered when compared with the CON group. Th e RA and Ang II levels in the ventricle of the ALI group were signifi cantly lower than those in the DOC group. Moreover, the expressions of ERK/, PERK/ and MMP were the lowest in the CON group, but those in the ALI group were signifi cantly reduced as compared to the DOC group. ALI can inhibit the DOCA induced myocardial fi brosis independent of its pressure-lowing eff ect, which may be related to the suppression of RA and Ang II production, inhibition of ERK/ phosphorylation and MMP expression in the heart. ©  Association of Basic Medical Sciences of FBIH. All rights reserved KEY WORDS: Aliskiren, deoxycorticosterone, myocardial fi brosis, renin-angiotensin -aldosterone system
INTRODUCTION
Myocardial fibrosis is a common pathological feature shared by several heart diseases at the end stage. To prevent or even reverse myocardial fi brosis has been a key goal in the prevention and treatment of severe cardiovascular events including heart failure, arrhythmia and sudden cardiac death. Studies have demonstrated that renin -angiotensin -aldosterone system (RAAS) plays important roles in the regulation of myocardial collagen metabolism and the occurrence of myocardial fi brosis [, ] . Evidence shows Aliskiren (ALI), a new rennin inhibitor, can not only lower the blood pressure, but improve the myocardial fi brosis and subsequent remodeling via its anti-infl ammatory and antioxidative eff ects [, ] . Currently, the anti-fi brotic eff ect of ALI and its potential mechanism are less studied. Th e present study aimed to investigate the cardioprotective effect of ALI on the deoxycorticosterone (DOCA) induced myocardial fi brosis and its potential mechanism in a rat model.
MATERIALS AND METHODS
Reagents ALI (Novartis, Switzerland), DOCA (Sigma, USA), primary antibodies against β-actin, extracellular signal kinase / (ERK/), phosphorylated ERK/ (PERK/) and metalloproteinase- (MMP-) (Santa Cruz, USA), secondary antibodies, two -quinolinecarboxylic acid (BCA) (Beijing Zhongshan Golden-Bridge Biotech, China), electrochemiluminescence (ECL) kit (Pierce), Sirius red (Beijing Haide Biotech, China) and radioimmunoassay kit (Beijing Yuanzi Biotech, China) were used in the present study.
Grouping and modelling
A total of  Sprague-Dawley (SD) male rats weighing ~ g were purchased from the Animal Center of Anhui Medical University. Th e investigation conforms with the Guide for Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication, th edition). Animals were randomly assigned into  groups (n= per group): control (CON) group, DOCA (DOC) group and ALI (ALI) group. Following anesthesia with intraperitoneal  chloral hydrate ( mg/kg), right nephrectomy was done in these animals. One week after surgery, animals were given access to  NaCl and received following treatments. In the CON group, silicone tube was embedded subcutaneously in the left lower abdomen. In the DOC group,  mg of DOCA were embedded in the left lower abdomen. In the ALI group,  mg of DOCA were embedded in the left lower abdomen and animals were intragastrically treated with ALI at  mg/kg/d for  weeks. In addition, animals in the CON group and DOC group were also intragastrically treated with normal saline for consecutive  weeks.
Measurement of blood pressure and sample collection
At the end of treatment, rats were intraperitoneally anesthetized with  chloral hydrate followed by cannulation of right carotid artery for the measurement of mean arterial blood pressure (MABP) using a multi-channel physiological recorder. Th en,  ml of blood were collected into the anti-coagulated tube and rats were sacrifi ced by exsanguinations. Th oracotomy was performed and the heart collected. The atrium, major vessels and connective tissues were removed and the left ventricle was divided into two: one was fi xed in  paraformaldehyde followed by processing for histological staining for collagen; the other was stored at - o C for the detection of protein expression by western blot assay. Blood was centrifuged at  rpm/min for  min and the plasma was collected and stored at - o C for use.
Detection of myocardial fi brosis
Th e heart tissues were embedded in the paraffi n and cut into sections followed by Sirius red staining for collagen. A total of  fi elds without blood vessels were randomly selected from each section and representative photographs were captured with Nikon camera followed by analysis using Image-Pro plus . image analysis system. Th e collagen area and total area of each fi eld were measured, and myocardial collagen volume fraction (CVF) was calculated as collagen area / total area. Th e CVFs from  fi elds were averaged and used as the final CVF of this sample. In addition,  fields with small blood vessels at cross section were randomly collected, and the perivascular collagen volume area (PVCA) and lumen area (LA) determined. The PVCA was normalized by the LA (PVCA/LA). Th e PVCAs from  fi elds were averaged and used as the fi nal PVCA of this sample.
Detection of renin and angiotensin II by radioimmunoassay
Briefly, in each group,  mg of ventricle were homogenized, and then the homogenate and plasma were independently divided into two: one was kept at  o C for  h which may facilitate the binding of renin (RA) to angiotensinogen producing angiotensin I (Ang I) (experiment group); the other was stored at  o C serving as controls. Th e Ang I level in the experiment group and control group was measured by radioimmunoassay according to the manufacturer's instructions. The difference in Ang I between experiment group and control group was normalized by the time of incubation as the production rate of Ang I. The production rate of Ang I in unit time was defi ned as the renin activity of this sample and the unit was ng /ml/h. According to the manufacturer's instructions, the Ang II level in the plasma and ventricle was also measured and its unit was pg/ml.
Detection of ERK/, PERK/ and MMP expressions in the ventricle by Western blot assay
Th e ventricle was homogenized and total protein extracted followed by detection of protein concentration. Th en, the protein concentration of different sample was adjusted to the same level and  μg of proteins were subjected to polyacrylamide gel electrophoresis. Th e protein was transferred onto nitrocellulose membrane. Following washing and blocking overnight, the membrane was treated with primary antibody (:) at room temperature for  h under continuous shaking. After washing, the membrane was incubated with secondary antibody (:) at room temperature for  h under continuous shaking. Visualization was done using ECL kit and X-ray fi lm was obtained. Th e bands were scanned using Bio-Rad image system and the optical density (OD) was determined followed by analysis with Quantity-one. Th e OD of target genes was normalized by that of β-actin as the relative expression of target genes.
Statistical analysis
Statistical analysis was performed using SPSS version .. Qualitative data were expressed as mean ± standard deviation (X±s). Means among groups were compared with one way analysis of variance, and comparisons of rate were done with chi square test. A value of p<. was considered statistically significant.
RESULTS

MABP in diff erent groups
Th e MABP in the DOC group and ALI group was .±. kPa and .±. kPa, respectively, which were markedly higher than that in the CON group (.±. kPa) (p<.). However, there was no significantly difference between DOC group and ALI group (p>.).
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Collagen content in the ventricle of diff erent groups
Following Sirius red staining, the collagens were scarlet and non-collagen tissues yellow (Figure . and .) . Th e CVF and PVCA in diff erent groups are shown in Table  . When compared with the control group, the CVF and PVCA in the DOC group and ALI group were markedly increased (p<. and p<., respectively). However, the CVF and PVCA in the ALI group was dramatically lower than those in the DOC group (p<. and p<., respectively). Th is fi nding implies ALI improves the DOC induced myocardial fi brosis.
RA and Ang II levels in the plasma and ventricle
The RA level of the plasma and ventricle of DOC group and ALI group was significantly lower than those in the CON group (p<. or p<.). Signifi cant diff erence in the RA level was found in the ventricle between DOC group and ALI group (p<.), but marked diff erence was absent in the RA level of the plasma (p>.). Th e Ang II level of the plasma and ventricle of the DOC group and ALI group was also significantly decreased when compared with CON group (p<.). Significant difference in the Ang II level was observed between ALI group and DOC in the ventricle (p<.) but not in the plasma (p>.)( Table ) .
Protein expressions of ERK/, PERK/ and MMP- in the ventricle
The protein expressions of ERK/, PERK/ and MMP- are shown in Figure  . Analysis showed the expressions of ERK/, PERK/ and MMP- in the CON group were the lowest, followed by ALI group, and those in the DOC group the highest. Significant difference in the expressions of ERK/, PERK/ and MMP- was found between any two groups (p<.). Moreover, the expressions of ERK/, PERK/ and MMP- in the ALI group were significantly higher than those in the CON (p<.) but lower than those in the DOC group (p<. or p<.).
DISCUSSION
In the present study, the DOCA induced myocardial fibrosis rat model was employed and the anti-fibrotic ef- Myocardial fi brosis refers to the aberrant deposition of extracellular matrix (ECM) in the heart, and characterized by increase of collagen in the interstitium, imbalance and irregular arrangement of diff erent types of collagen. Th e imbalance between the synthesis and degradation of collagen is a major cause of myocardial fi brosis. Under the pathological conditions, the proliferation and phenotype of cardiac fi broblasts change and these cells produce a large amount of collagens resulting in imbalance between type I and type II collagens and subsequent deposition of collagens between myocardial cells. MMPs play critical role in the myocardial fi brosis through affecting the degradation of ECM. MMP can degrade normal collagens such as gelatin, elastin, collagen type IV collagen, type V collagen and mucin but has no infl uence on abnormal collagens [] . In the myocardial fi brosis, the myocardial interstitium is occupied by abnormal collagens (mainly type I and III collagens). Under pathological conditions, the MMP- expression is increased and then degrades the normal collagens. Th us, the myocardial interstitium between myocardial cells loses and a large amount of abnormal collagens generated. Westermann et al. [] investigated the effect of ALI on the rat myocardial infarction. Th eir results showed ALI could reduce the deposition of collagen in the infarction region and subsequent myocardial fibrosis via reducing the MMP- activity. Our results also revealed the MMP- expression was markedly elevated in rats with DOCA induced myocardial fibrosis accompanied by increased extracellular deposition of collagen. However, following ALI treatment, the MMP- expression and deposition of collagen were markedly decreased and myocardial fi brosis improved. In addition, studies have shown that RAAS plays an important role in the regulation of collagen metabolism in the heart and blood vessels, and Ang II and aldosterone are two major eff ector proteins [, ] . Th ere is evidence that angiotensinconverting enzyme inhibitors (ACEI), angiotensin receptor blockers (ARB) and aldosterone receptor antagonists can significantly improve the fibrosis [] . However, long-term application of ACEI and ARB may lead to the Ang II escape [] . It has been confirmed that Ang II can be synthesized via both ACE-dependent and ACE-independent pathways. Continuous use of ACEI and ARB may cause accumulation of Ang I and activate ACE-independent pathways resulting in increase in Ang II. Of note, - of Ang II in the tissues is synthesized via ACE-independent pathways [] . ALI, a renin inhibitor, acts on the fi rst rate-limiting step of RAAS chain and blocks the activation of RAAS leading to the decrease in Ang II and aldosterone production [] . Th us, theoretically, ALI has potent anti-fi broric eff ect on myocardial fi brosis. Singh et al. [] showed, in streptomycin induced hyperglycemia rats, the ALI was superior to benazepril and losartan in improving myocardial fi brosis and apoptosis of myocardial cells. In the present study, the blood pressure was not dramatically lowered following administration of ALI, but the DOCA induced myocardial fi brosis was obviously improved. Studies showed the ventricular RAAS plays a more critical role in the myocardial fi brosis than circulation RAAS does [, ] . Our study further confi rmed the RA and Ang II in the circulation were largely unchanged followed ALI treatment, but those in the heart were dramatically decreased. These findings suggest the anti-fibrotic effect of ALI is related to the suppression of local Ang II production. Currently, the mechanisms underlying the anti-fi brotic eff ect of ALI are not completely clear. Our results showed the antifi brotic eff ect of ALI may be attributed to the suppression of phosphorylation of ERK/ signaling pathway. In recent years, studies show the Ang II/angiotensin receptor  (ATR) mediated myocardial fi brosis is related to the ERK/ signaling pathway [] . Th e binding of Ang II to ATR can activate the phospholipase C on the cell membrane resulting in the hydrolysis of phosphatidylinositol phosphate and production of diacylglycerol. Th e later promotes the release of Ca + in the sarcoplasmic reticulum and endoplasmic reticulum. Ca + can act as a second messenger to activate ERK/ signaling pathway. Th e activation of ERK/ signaling pathway may facilitate the transcription of early response genes (such as c-fos) in the cardiac fibroblasts, skeletal muscle α-actin gene, β-myosin heavy chain gene and embryonic contractile protein gene and promote the expression of growth factors in fi broblasts. In addition, a large amount of ECM and collagen are produced, the proliferation of fi broblasts promoted and expressions of Iα and IIIα increased resulting in myocardial fi brosis [, ] . Our results showed the expressions of ERK/ and PERK/ in the ALI group were markedly decreased when compared with the DOC group. We speculate that ALI can decrease the production of AngII and local RA to reduce the Ang II/ATR induced activation of ERK/, which fi nally exerts the anti-fi brotic eff ects.
CONCLUSION
Evidence shows that RAAS plays important roles in the occurrence of myocardial fibrosis and ALI has anti-fibrotic effect via its anti-inflammatory and anti-oxidative effects. Th e present study demonstrates that ALI as an inhibitor of renin can improve the DOCA induced myocardial fi brosis, which may be attributed to the suppression of myocardial RAAS, decrease in Ang II level and inhibition of phosphorylation of ERK/ signaling pathway and MMP- expression. However, more studies are required to confi rm our results.
